Investment for the future
CSL Behring had the pleasure of awarding the three best Master's Degrees in Biomedical Sciences at the University of Bern.
Results from Clinical Trial of COVID-19 Hyperimmune
CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune …
A Research Catalyst in Switzerland
A new partnership between CSL Behring and Biopôle takes shape, pairing the global biotech with one of the most dynamic life s…
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
Take the Rare Disease Day Quiz!
Test your knowledge about rare diseases, which affect more people than you think.
What to Tell the Kids About COVID-19?
A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.